Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Vanda Pharmaceuticals Inc. (VNDA)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues:  
    Product sales  268.7248.2227.2193.1165.1 109.912.9
    Royalty revenue         6.5
    Licensing agreement         30.7
Total revenues   [+]268.7248.2227.2193.1165.1146.0109.950.2
            Revenue growth   [+]8.3%9.2%17.6%17.0%13.1%32.8%119.2%48.0%
Cost of goods sold  25.623.424.520.517.824.723.51.6
Gross profit  243.1224.8202.7172.6147.2121.386.548.6
            Gross margin  90.5%90.6%89.2%89.4%89.2%83.1%78.7%96.8%
Selling, general and administrative  124.0140.5129.7105.8123.899.884.584.6
Research and development  75.455.648.643.638.529.229.119.2
Other operating expenses       10.913.02.3
EBITDA   [+]45.030.125.724.7-13.9-6.7-26.6-54.8
            EBITDA margin  16.8%12.1%11.3%12.8%-8.4%-4.6%-24.2%-109.2%
Depreciation  1.41.41.41.41.20.90.60.5
EBITA  43.628.724.323.3-15.2-7.6-27.2-55.3
            EBITA margin  16.2%11.6%10.7%12.0%-9.2%-5.2%-24.8%-110.3%
Amortization of intangibles  1.51.51.51.51.810.913.02.3
EBIT   [+]42.227.222.821.7-16.9-18.6-40.2-57.6
            EBIT margin  15.7%11.0%10.0%11.3%-10.2%-12.7%-36.6%-114.7%
Non-recurring items   [+]       -77.6
Other income (expense), net  0.24.46.23.61.50.70.30.1
Pre-tax income  42.431.729.025.3-15.4-17.9-39.920.2
Income taxes  9.28.3-86.50.10.10.10.00.0
            Tax rate  21.7%26.3% 0.5%  0.0%0.0%
Net income  33.223.3115.625.2-15.6-18.0-39.920.2
            Net margin  12.3%9.4%50.9%13.1%-9.4%-12.3%-36.3%40.2%
   
Basic EPS   [+]$0.60$0.43$2.17$0.50($0.35)($0.41)($0.94)$0.58
Diluted EPS   [+]$0.58$0.42$2.11$0.48($0.35)($0.41)($0.94)$0.55
   
Shares outstanding (basic)   [+]55.554.453.150.944.743.442.334.8
Shares outstanding (diluted)   [+]56.955.254.853.044.743.442.336.7
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy